These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12671668)

  • 1. Challenges to cancer control by screening.
    Pollak MN; Foulkes WD
    Nat Rev Cancer; 2003 Apr; 3(4):297-303. PubMed ID: 12671668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The case for early detection.
    Etzioni R; Urban N; Ramsey S; McIntosh M; Schwartz S; Reid B; Radich J; Anderson G; Hartwell L
    Nat Rev Cancer; 2003 Apr; 3(4):243-52. PubMed ID: 12671663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some issues in screening for breast and other cancers.
    Duffy SW; McCann J; Godward S; Gabe R; Warwick J
    J Med Screen; 2006; 13 Suppl 1():S28-34. PubMed ID: 17227639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening program.
    Hamashima C; Sobue T; Muramatsu Y; Saito H; Moriyama N; Kakizoe T
    Jpn J Clin Oncol; 2006 May; 36(5):301-8. PubMed ID: 16735372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic markers for ovarian cancer screening: not ready for routine clinical use.
    Coates RJ; Kolor K; Stewart SL; Richardson LC
    Clin Cancer Res; 2008 Nov; 14(22):7575-6; author reply 7577-9. PubMed ID: 18948387
    [No Abstract]   [Full Text] [Related]  

  • 6. Limitations of screening. Why population-based screening doesn't always work.
    Benson P
    Minn Med; 1996 Oct; 79(10):12-3, 59. PubMed ID: 8937048
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk-adapted multimodal laboratory cervical screening -- application of new technologies to cervical cancer prevention.
    Bollmann R; Bankfalvi A; Bollmann M
    Croat Med J; 2005 Jun; 46(3):361-7. PubMed ID: 15861512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
    Höltl W; Lunglmayr G
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer screenings, diagnostic technology evolution, and cancer control.
    Stracci F
    Methods Mol Biol; 2009; 471():107-36. PubMed ID: 19109777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can cancer be diagnosed with a blood test during routine examinations?
    Weiss PA; Weiss PA
    Clin J Oncol Nurs; 2007 Dec; 11(6):940-1. PubMed ID: 18063553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NMR research on blood plasma for tumor detection--a method for mass screening?].
    Fritzsche H; Sprinz H; Jahn H; Jorke D
    Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical issues in the evaluation of screening and early detection modalities.
    Etzioni R
    Urol Oncol; 2008; 26(3):308-15. PubMed ID: 18452826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour markers.
    Pandha HS; Waxman J; Sikora K
    Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):297-303. PubMed ID: 8032568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening and biomarkers.
    Brooks M
    Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for cancer with PET and PET/CT: potential and limitations.
    Schöder H; Gönen M
    J Nucl Med; 2007 Jan; 48 Suppl 1():4S-18S. PubMed ID: 17204716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New stool screening tests for colorectal cancer.
    Young GP; Cole S
    Digestion; 2007; 76(1):26-33. PubMed ID: 17947816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of prostate-specific antigen in prostate cancer.
    Liang SL
    MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer: screening and early detection.
    Tariman JD
    Adv Nurse Pract; 2006 Sep; 14(9):20. PubMed ID: 16972436
    [No Abstract]   [Full Text] [Related]  

  • 19. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
    Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
    Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.